Liu, Fangshu
Sun, Xiaofan
Deng, Suqi
Wu, Yingying
Liu, Xingcheng
Wu, Caiping
Huang, Kexiu
Li, Yue
Dong, Zexuan
Xiao, Weihao
Li, Manchun
Chen, Zhiyang
Ju, Zhenyu
Xiao, Jia
Du, Juan
Zeng, Hui https://orcid.org/0000-0002-4498-8888
Funding for this research was provided by:
Guangdong Science and Technology Department (2021B1515020017)
National Natural Science Foundation of China (No. 81970143)
National Natural Science Foundation of China (No. 82270167)
Article History
Received: 16 August 2023
Accepted: 28 July 2024
First Online: 7 August 2024
Declarations
:
: The animal study protocols were approved by the Institutional Animal Care and Use Committee (IACUC) of JINAN University under multiple approved proposals and listed below. 1.“CXCR3 regulates survival and self-renewal of hematopoietic stem/progenitor cells” This study was approved on April 25, 2021, with approval number IACUC: 20210425-03. 2.“CXCL10 regulates survival and self-renewal of hematopoietic stem/progenitor cells” This study was approved on April 25, 2021, with approval number IACUC: 20210425-04. 3.“CXCL10 -CXCR3- CXCL9 regulate survival and self-renewal of hematopoietic stem/progenitor cells”. This study was approved on April 29, 2021, with approval number IACUC: 20210429-13. 4. “CXCL10, CXCR3, CXCL9 regulate survival and self-renewal of hematopoietic stem/progenitor cells []”. This study was approved on June 4, 2021, with approval number IACUC: 20210607-04. 5.“CXCL10 and CXCR3 regulate hematopoietic stem progenitor cell differentiation and self-renewal”. This study was approved on October 22, 2021, with approval number IACUC: 20211022-010. All animal experiments were performed according to the National Institutes of Health guide for the care and use of laboratory animals on ethics.
: Not applicable.
: The authors declare no competing interests.